These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 147851)

  • 41. Nutritional pharmacology.
    DiPalma JR
    Am Fam Physician; 1985 Aug; 32(2):171-3. PubMed ID: 2992258
    [No Abstract]   [Full Text] [Related]  

  • 42. Therapeutic strategies against tardive dyskinesia. Two decades of experience.
    Jeste DV; Wyatt RJ
    Arch Gen Psychiatry; 1982 Jul; 39(7):803-16. PubMed ID: 6131655
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A double blind trial of sulpiride in Huntington's disease and tardive dyskinesia.
    Quinn N; Marsden CD
    J Neurol Neurosurg Psychiatry; 1984 Aug; 47(8):844-7. PubMed ID: 6236286
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of tardive dyskinesia with choline and tetrabenazine.
    Snell AP; Cleary M; Sambrook M
    Postgrad Med J; 1980 Sep; 56(659):663-4. PubMed ID: 7465478
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lecithin consumption increases acetylcholine concentrations in rat brain and adrenal gland.
    Hirsch MJ; Wurtman RJ
    Science; 1978 Oct; 202(4364):223-5. PubMed ID: 694529
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Depression associated with oral choline.
    Tamminga C; Smith RC; Chang S; Haraszti JS; Davis JM
    Lancet; 1976 Oct; 2(7991):905. PubMed ID: 62133
    [No Abstract]   [Full Text] [Related]  

  • 47. Food consumption, neurotransmitter synthesis, and human behaviour.
    Wurtman RJ
    Experientia Suppl; 1983; 44():356-69. PubMed ID: 6139295
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Deanol acetamidobenzoate inhibits the blood-brain barrier transport of choline.
    Millington WR; McCall AL; Wurtman RJ
    Ann Neurol; 1978 Oct; 4(4):302-6. PubMed ID: 727735
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pathways of acetylcholine synthesis, transport and release as targets for treatment of adult-onset cognitive dysfunction.
    Amenta F; Tayebati SK
    Curr Med Chem; 2008; 15(5):488-98. PubMed ID: 18289004
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dietary precursors and brain neurotransmitter formation.
    Fernstrom JD
    Annu Rev Med; 1981; 32():413-25. PubMed ID: 6111981
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Choline and lecithin administration to patients with tardive dyskinesia.
    Growdon JH; Gelenberg AJ
    Trans Am Neurol Assoc; 1978; 103():95-9. PubMed ID: 757093
    [No Abstract]   [Full Text] [Related]  

  • 52. Nutrients and neurotransmitters.
    Growdon JH; Wurtman RJ
    N Y State J Med; 1980 Sep; 80(10):1638-9. PubMed ID: 6106917
    [No Abstract]   [Full Text] [Related]  

  • 53. Pharmacotherapeutic trials in tardive dyskinesia.
    Mackay AV; Sheppard GP
    Br J Psychiatry; 1979 Dec; 135():489-99. PubMed ID: 43753
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Central cholinergic function: relationship to choline administration.
    Wecker L; Schmidt DE
    Life Sci; 1979 Jul; 25(4):375-84. PubMed ID: 470558
    [No Abstract]   [Full Text] [Related]  

  • 55. Possible dietary strategies to reduce cognitive deficits in old age.
    Lieberman HR; Abou-Nader TM
    Prog Brain Res; 1986; 70():461-71. PubMed ID: 2883705
    [No Abstract]   [Full Text] [Related]  

  • 56. Systematic review of cholinergic drugs for neuroleptic-induced tardive dyskinesia: a meta-analysis of randomized controlled trials.
    Tammenmaa IA; Sailas E; McGrath JJ; Soares-Weiser K; Wahlbeck K
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Nov; 28(7):1099-107. PubMed ID: 15610922
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of chronic dyskinesia with CDP-choline.
    Arranz J; Ganoza C
    Arzneimittelforschung; 1983; 33(7A):1071-3. PubMed ID: 6684469
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CDP-choline for the treatment of tardive dyskinesia: a small negative series.
    Gelenberg AJ; Wojcik J; Falk WE; Bellinghausen B; Joseph AB
    Compr Psychiatry; 1989; 30(1):1-4. PubMed ID: 2647398
    [TBL] [Abstract][Full Text] [Related]  

  • 59. When--and why--should nutritional state control neurotransmitter synthesis?
    Wurtman RJ
    J Neural Transm Suppl; 1979; (15):69-79. PubMed ID: 39979
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Deanol in the management of involuntary movement disorders: a review.
    Casey DE
    Dis Nerv Syst; 1977 Dec; 38(12 Pt 2):7-15. PubMed ID: 145359
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.